Related references
Note: Only part of the references are listed.IL-3 Inhibits TNF-alpha-Induced Bone Resorption and Prevents Inflammatory Arthritis
S. D. Yogesha et al.
JOURNAL OF IMMUNOLOGY (2009)
Receptor activator NF κB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis
T Crotti et al.
JOURNAL OF PERIODONTAL RESEARCH (2003)
Neutrophil serine proteinases activate human nonepithelial cells to produce inflammatory cytokines through protease-activated receptor 2
A Uehara et al.
JOURNAL OF IMMUNOLOGY (2003)
Suppression of alveolar bone resorption by etidronate treatment for periodontal disease: 4-to 5-year follow-up of four patients
Y Takaishi et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2003)
TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis
AR Pettit et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Clinical effect of etidronate on alveolar pyorrhoea associated with chronic marginal periodontitis: Report of four cases
Y Takaishi et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2001)
Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection
YTA Teng et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
